DEUTSCHE BANK AG\ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 15 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$3,951,000
+115.7%
4,000,000
+100.0%
0.00%0.0%
Q1 2018$1,832,000
+388.5%
2,000,000
+312.4%
0.00%
Q2 2017$375,000
+77.7%
485,000
+44.3%
0.00%
Q1 2017$211,000
-73.5%
336,000
-74.9%
0.00%
-100.0%
Q4 2016$795,000
-74.2%
1,336,000
-77.0%
0.00%
-50.0%
Q3 2016$3,077,0005,807,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 24,877,000$28,400,0000.91%
DeepCurrents Investment Group LLC 11,130,000$12,770,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 39,676,000$45,851,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 20,454,000$23,593,0000.27%
PALISADE CAPITAL MANAGEMENT, LP 2,300,000$2,645,0000.08%
Verition Fund Management LLC 2,762,000$3,197,0000.06%
LOOMIS SAYLES & CO L P 240,850$11,568,0000.02%
Allianz Asset Management GmbH 16,525,000$19,009,0000.02%
D. E. Shaw & Co., Inc. 8,443,000$9,732,0000.01%
CREDIT SUISSE AG/ 12,393,000$14,296,0000.01%
View complete list of PTC THERAPEUTICS INC shareholders